COSCIA, Marta
COSCIA, Marta
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS
2014-01-01 Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment
2015-01-01 Serra, S; Brusa, D; Vaisitti, T; Buonincontri, R; Audrito, V; Coscia, M; Rossi, D; Bhavsar, Eb; Furman, Rr; Gaidano, G; Deaglio, S
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS
2015-01-01 Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr
AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS
2015-01-01 Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Pasquale, R; Sica, S; Laurenti, L
B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide
2018-01-01 Fuerstenau, Moritz; Fink, Anna-Maria; Herling, Carmen; Maurer, Christian; Kutsch, Nadine; De La Serna, Javier; Coscia, Marta; Crespo, Marta; Bosch, Francesc; Noesslinger, Thomas; Ghia, Paolo; Kater, Arnon P.; Ritgen, Matthias; Schilhabel, Anke; Stilgenbauer, Stephan; Tausch, Eugen; Fischer, Kirsten; Hallek, Michael J.; Eichhorst, Barbara
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL
2011-01-01 Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M
Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia
2017-01-01 Diop, F; Moia, R; Favini, C; Spaccarotella, E; De Paoli, L; Bruscaggin, A; Spina, V; Cerri, M; Deambrogi, C; Kodipad, AA; Favini, S; Sagiraju, S; Jabangwe, C; Mauro, FR; Del Giudice, I; Forconi, F; Cortelezzi, A; Zaja, F; Visco, C; Chiarenza, A; Rigolin, GM; Marasca, R; Coscia, M; Perbellini, O; Tedeschi, A; Laurenti, L; Motta, M; Del Poeta, G; Cuneo, A; Gattei, V; Foa, R; Gaidano, G; Rossi, D
BTK and PLCG2 mutations in patients with Chronic Lymphocytic Leukemia relapsing on Ibrutinib: a European Research Initiative on CLL (ERIC) study based on real-world evidence
2020-01-01 L Scarfò, S Bonfiglio, L A Sutton, V Ljungstrom, T Pandzic, D Cortese, G Gaidano, L Trentin, L Bonello, G Reda, P Panayiotidis, F Forconi, N Stavroyianni, C Bödör, C Tam, S Iyengar, A Österborg, M Coscia, L Ysebaert, O Jaksic, I Ringshausen, S Mulligan, A Tedeschi, V Strugov, Z Davis, C Pavlovsky, R Marasca, A Capasso, P Ranghetti, K Stamatopoulos, R Rosenquist, P Ghia
CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA
2018-01-01 D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells
2011-01-01 Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification
2016-01-01 Laurenti, L; Innocenti, I; Autore, F; Pasquale, R; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, M; Coscia, M; Molica, S; Pozzato, G; Efremov, Dg; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, Di; Liberati, Am; Russo, F; Foa, R
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: a multicentric italian survey
2012-01-01 D'Arena G; Laurenti L; Del Poeta G; Grossi A; Coscia M; Mometto G; Chiarenza A; Selleri C; Vigliotti ML; Pozzato G; Nunziata G; La Sala A; Villa MR; Simeon V; Deaglio S; De Feo V; Musto P
Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells
2006-01-01 Francesca Fiore; Barbara Castella; Barbara Nuschak; Raffaello Bertieri; Sara Mariani; Serena Zappia; Marta Coscia; Mario Boccadoro; Massimo Massaia
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
2009-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A PHASE II MULTI-CENTER TRIAL OF PENTOSTATIN PLUS CYCLOPHOSPHAMIDE WITH OFATUMUMAB (PCO) IN OLDER PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS | 2014 | Montillo, M; Rossi, D; Motta, M; Quaresmini, G; Rossi, M; Coscia, M; Anastasia, A; Rossini, F; Cortellezzi, A; Nador, G; Scarfo, L; Cairoli, R; Frustaci, Am; Dal Ceggio, D; Picardi, P; De Paoli, L; Orlandi, E; Rambaldi, A; Morra, E; Massaia, M; Tedeschi, A | |
| Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta | |
| Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
| Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment | 2015 | Serra, S; Brusa, D; Vaisitti, T; Buonincontri, R; Audrito, V; Coscia, M; Rossi, D; Bhavsar, Eb; Furman, Rr; Gaidano, G; Deaglio, S | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE PLUS RITUXIMAB TREATMENT IN CLL PATIENTS | 2015 | Laurenti, L; Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Bellesi, S; Efremov, D; Sica, S; Mauro, Fr | |
| AUTOIMMUNE HAEMOLYTIC ANAEMIA DURING BENDAMUSTINE TREATMENT IN CLL PATIENTS | 2015 | Autore, F; Innocenti, I; D'Arena, G; Coscia, M; Mondello, P; Pasquale, R; Sica, S; Laurenti, L | |
| B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide | 2018 | Fuerstenau, Moritz; Fink, Anna-Maria; Herling, Carmen; Maurer, Christian; Kutsch, Nadine; De La Serna, Javier; Coscia, Marta; Crespo, Marta; Bosch, Francesc; Noesslinger, Thomas; Ghia, Paolo; Kater, Arnon P.; Ritgen, Matthias; Schilhabel, Anke; Stilgenbauer, Stephan; Tausch, Eugen; Fischer, Kirsten; Hallek, Michael J.; Eichhorst, Barbara | |
| Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo | |
| BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL | 2011 | Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M | |
| Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
| BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia | 2017 | Diop, F; Moia, R; Favini, C; Spaccarotella, E; De Paoli, L; Bruscaggin, A; Spina, V; Cerri, M; Deambrogi, C; Kodipad, AA; Favini, S; Sagiraju, S; Jabangwe, C; Mauro, FR; Del Giudice, I; Forconi, F; Cortelezzi, A; Zaja, F; Visco, C; Chiarenza, A; Rigolin, GM; Marasca, R; Coscia, M; Perbellini, O; Tedeschi, A; Laurenti, L; Motta, M; Del Poeta, G; Cuneo, A; Gattei, V; Foa, R; Gaidano, G; Rossi, D | |
| BTK and PLCG2 mutations in patients with Chronic Lymphocytic Leukemia relapsing on Ibrutinib: a European Research Initiative on CLL (ERIC) study based on real-world evidence | 2020 | L Scarfò, S Bonfiglio, L A Sutton, V Ljungstrom, T Pandzic, D Cortese, G Gaidano, L Trentin, L Bonello, G Reda, P Panayiotidis, F Forconi, N Stavroyianni, C Bödör, C Tam, S Iyengar, A Österborg, M Coscia, L Ysebaert, O Jaksic, I Ringshausen, S Mulligan, A Tedeschi, V Strugov, Z Davis, C Pavlovsky, R Marasca, A Capasso, P Ranghetti, K Stamatopoulos, R Rosenquist, P Ghia | |
| CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA | 2018 | D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L | |
| CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells | 2011 | Sara Serra; Alberto Horenstein; Tiziana Vaisitti; Davide Brusa; Davide Rossi; Luca Laurenti; Giovanni D'Arena; Marta Coscia; Claudio Tripodo; Giorgio Inghirami; Simon Robson; Gianluca Gaidano; Fabio Malavasi; Silvia Deaglio | |
| Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
| Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification | 2016 | Laurenti, L; Innocenti, I; Autore, F; Pasquale, R; Vannata, B; Ciolli, S; Mauro, Fr; Mannina, D; Del Poeta, G; D'Arena, G; Massaia, M; Coscia, M; Molica, S; Pozzato, G; Efremov, Dg; Marasca, R; Galieni, P; Cuneo, A; Orlando, S; Piciocchi, A; Boncompagni, R; Vincelli, Di; Liberati, Am; Russo, F; Foa, R | |
| Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: a multicentric italian survey | 2012 | D'Arena G; Laurenti L; Del Poeta G; Grossi A; Coscia M; Mometto G; Chiarenza A; Selleri C; Vigliotti ML; Pozzato G; Nunziata G; La Sala A; Villa MR; Simeon V; Deaglio S; De Feo V; Musto P | |
| Dendritic Cells Can Be Primed to Concurrently Activate Both Unconventional Gamma/delta and Conventional alpha/beta T Cells | 2006 | Francesca Fiore; Barbara Castella; Barbara Nuschak; Raffaello Bertieri; Sara Mariani; Serena Zappia; Marta Coscia; Mario Boccadoro; Massimo Massaia | |
| Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis | 2009 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia |